FDA and the White House helped to broker a deal preserving the agency's role in approving emergency medical products needed for troops -- a deal that a House leadership aide told Inside Health Policy will be taken up on the House floor Wednesday (Nov. 15). The language will be considered as a sidecar bill clarifying controversial language in the 2018 Defense authorization bill that would have given the role to the Department of Defense (DOD). The sidecar bill, to be...